NON-SMALL CELL LUNG CANCER STAGE II

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE II:

# Drug Count
0 METHOTREXATE SODIUM 6
1 ETANERCEPT 5
2 ADALIMUMAB 3
3 DEXAMETHASONE 3
4 DEXAMETHASONE 1.5 MG 3
5 FUROSEMIDE 3
6 METHOTREXATE 3
7 ATORVASTATIN CALCIUM 2
8 CELECOXIB 2
9 LENALIDOMIDE 2
See all common drugs associated with NON-SMALL CELL LUNG CANCER STAGE II

NON-SMALL CELL LUNG CANCER STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEMECLOCYCLINE 1 0.0044
1 FOSINOPIRL SODIUM 1 0.0005
2 FOSINOPRIL 1 0.0002
3 ITRACONAZOLE 1 0.0001
4 CEFAZOLIN SODIUM 1 0.0001
5 ERLOTINIB HYDROCHLORIDE 1 0.0001
6 AMPHOTERICIN B 1 0.0001
7 CEFEPIME HYDROCHLORIDE 1 0.0001
8 VORICONAZOLE 1 0.0000
9 RISEDRONATE SODIUM 1 0.0000
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER STAGE II